Andrew is the founder and CEO of Leven Therapeutics Inc., a leading Canadian cannabis brokerage specializing in B2B flower and biomass transactions across domestic and international markets including Germany, the UK, Switzerland, and Australia. With a deep focus on quality, compliance, and market intelligence, Andrew has built Leven into a trusted platform that connects small craft growers, greenhouse cultivators, and large-scale producers with domestic and global buyers.
At the heart of Leven’s model is the proprietary Leven Approved program — a validation system that vets and certifies producers across key metrics including quality, consistency, business acumen and compliance. Building on that foundation, Andrew recently launched Sun Certified, a new standard recognizing sustainable, sun-grown cannabis cultivated with low environmental impact — an initiative designed to support regenerative agriculture and further distinguish premium outdoor flower for the new domestic and international SKUs.
Under Andrew’s leadership, Leven has expanded into short-term financing solutions for buyers, real-time price tracking, and AI-powered tools for compliance automation — addressing some of the most critical challenges in the global cannabis supply chain. He also publishes Leven Cannabis Magazine, a publication dedicated to highlighting the people, products, and policies shaping the future of cannabis commerce.
Andrew continues to drive innovation in cannabis logistics, trade facilitation, and market access, positioning Leven as a key force in the global cannabis economy.
